NIAID Clinic Results Good News for HIV
By Catherine Shaffer
Friday, May 13, 2011
Interim review of a Phase III trial by the National Institute of Allergy and Infectious Diseases (NIAID) showed a striking benefit of the use of antiretroviral therapy for the partners of HIV-infected individuals. An independent data and safety monitoring board (DSMB) released the results ahead of the trial's scheduled 2015 end date because the results were so clear.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.